⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
SCYX News
SCYNEXIS, Inc.
Poxel: Report de la publication des comptes annuels 2025 et du rapport financier annuel
businesswire.com
SCYX
Form 8-K
sec.gov
SCYX
Form 8-K
sec.gov
SCYX
Poxel annonce la cession du PXL770 à la société Scynexis pour un montant total pouvant atteindre jusqu’à 196 millions de dollars
businesswire.com
SCYX
Poxel Announces the Sale of PXL770 to Scynexis for a Total Amount of up to $196 Million
businesswire.com
SCYX
Form 8-K
sec.gov
SCYX
Form 8-K
sec.gov
SCYX
SCYNEXIS Announces $40.0 Million Private Placement
globenewswire.com
SCYX
SCYNEXIS Completes Transformative Acquisition of PXL-770, an innovative, highly selective, direct AMPK activator for the Treatment of Autosomal Dominant Polycystic Kidney Disease (ADPKD)
globenewswire.com
SCYX
SCYNEXIS Reports Full Year 2025 Financial Results and Provides Corporate Update
globenewswire.com
SCYX